Leading developer of 'smart' cannabis devices makes entrance into Europe, Brazil, and Caribbean markets
TORONTO, Nov. 28, 2018 /CNW/ -- Resolve Digital Health ("Resolve" or the "Company"), a Canada-based developer of cannabis formulations, brands and smart devices, is pleased to announce that it has entered into a strategic partnership with Jamaican Medical Cannabis Corporation Ltd. (JMCC), a Canadian-Jamaican medical cannabis exporter. Under the terms of the agreement, JMCC will supply both the high-quality medicinal cannabis, and processing, packaging and distribution services for Resolve's ecosystem of smart inhaler pods in its key markets outside of North America. The deal is expected to close by December 31, 2018.
"As more countries adopt the use of medical cannabis and as a growing body of research expands the number of conditions for which medical cannabis treatments are indicated, Resolve anticipates steadily increasing growth from international sales," said Rob Adelson, CEO and founder of Resolve. "In order to address this global opportunity, we are expanding our capacity to produce world-class products to GMP standards and deliver worldwide via sophisticated distribution and logistics. JMCC is a perfect partner to assist us in achieving our expansion goals via this unique outsourcing arrangement."
The agreement also marks a natural extension of JMCC's current offering beyond cultivation and extraction, to provide custom processing, packaging and global distribution. The company is actively engaged with customers in Canada, Germany, Australia and other parts of the world.
"Our mission and ambitions have grown quickly from being the best cultivator and quality-focused provider of Jamaica's unique medical cannabis to the world, to providing a fully integrated product outsourcing solution to visionary companies like Resolve," said Diane Scott, Chair and CEO of JMCC. "This agreement enables both companies to focus on what each does best: Resolve is perfecting new applications for its remarkable products for patients and JMCC is managing the exacting production and delivery of those products to Resolve's new markets worldwide. It also reaffirms JMCC's commitment to job creation and further investment in Jamaica."
About Jamaican Medical Cannabis Corporation Ltd. (JMCC)
JMCC is a Canadian-headquartered group of companies with rapidly expanding medical cannabis operations in Jamaica. Providing a range of cultivars sun-grown in specially designed greenhouses at various locations around the island, JMCC also offers an integrated and customizable outsourcing solution for the global medical cannabis industry, including processing/extraction, testing, global warehousing and distribution. Led by an international executive team with in-depth experience in highly regulated industries, JMCC provides premium medicinal cannabis and associated services to licensed producers and other industry participants to free them to focus on creating and delivering the best products for patients.
For more information, please visit www.jamaicanmedicann.com.
About Resolve Digital Health
Resolve Digital Health is positioned to be the leading provider of a metered dosing ecosystem for cannabis devices for the health and wellness markets. The company's proprietary technology, apps and cloud-based health information platform address the numerous issues with currently available methods of cannabis delivery – establishing a data-driven standard of care and cutting-edge vaporizers for the cannabis industry. With over three years of research and development, the complete product ecosystem will be initially available in late 2018.
For more information, please visit www.resolvedigitalhealth.com.
SOURCE Resolve Digital Health
For further information: Media Contact for JMCC: Shelley Boyes, Global Director, Marketing & Communications, +1 416 272 8981, [email protected]; Contact for Resolve: Carrie Booze, North 6th Agency, 212-334-9753 ext.142, [email protected], http://www.resolvedigitalhealth.com
